Driehaus Capital Management LLC Seagen Inc. Transaction History

Driehaus Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $532,438 - $738,777	-3,872 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$164.63 - $211.93 $1.41 Million - $1.82 Million	-8,567 Reduced 68.87%	3,872 $678,000
Q3 2020 Nov 16, 2020	BUY	$145.95 - $195.69 $1.82 Million - $2.43 Million	12,439 New	12,439 $2.43 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.